Making Two Wrongs Right – Case of Using a Patient’s Diabetes insipidus to Treat HisHeart Failure: Experience with Vasopress in Antagonists from Animal Studies and Clinical Trials

Publisher： Karger

E-ISSN： 1424-0556|3|2|107-112

ISSN： 1422-9528

Source： Heart Drug, Vol.3, Iss.2, 2003-08, pp. : 107-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amphotericin B: Nephrogenic diabetes insipidus in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Propofol: Diabetes insipidus in a patient who had undergone a hypophysectomy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials

By Hernandez Adrian V.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 2, 2011-04 ,pp. : 115-128

Adis International

Access to resources Recommend Favorite

-Blockers in Heart Failure: The ‘New Wave’ of Clinical Trials

By Krum H.  

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 203-210

Adis International

Access to resources Recommend Favorite

Angiotensin receptor antagonists: Nephrogenic diabetes insipidus following in utero exposure: 2 case report

By  

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite